Number of the records: 1  

N-(2-hydroxypropyl)methacrylamide polymer conjugated pyropheophorbide-a, a promising tumor-targeted theranostic probe for photodynamic therapy and imaging

  1. 1.
    SYSNO ASEP0490803
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleN-(2-hydroxypropyl)methacrylamide polymer conjugated pyropheophorbide-a, a promising tumor-targeted theranostic probe for photodynamic therapy and imaging
    Author(s) Fang, J. (JP)
    Šubr, Vladimír (UMCH-V) RID, ORCID
    Islam, W. (JP)
    Hackbarth, S. (DE)
    Islam, R. (JP)
    Etrych, Tomáš (UMCH-V) RID, ORCID
    Ulbrich, Karel (UMCH-V) RID
    Maeda, H. (JP)
    Source TitleEuropean Journal of Pharmaceutics and Biopharmaceutics. - : Elsevier - ISSN 0939-6411
    Roč. 130, September (2018), s. 165-176
    Number of pages12 s.
    Languageeng - English
    CountryNL - Netherlands
    KeywordsEPR effect ; polymeric micelles ; macromolecular photosensitizers
    Subject RIVFR - Pharmacology ; Medidal Chemistry
    OECD categoryPharmacology and pharmacy
    R&D ProjectsNV16-28594A GA MZd - Ministry of Health (MZ)
    Institutional supportUMCH-V - RVO:61389013
    UT WOS000441855500018
    EID SCOPUS85049321770
    DOI10.1016/j.ejpb.2018.06.005
    AnnotationTumor-targeted photodynamic therapy (PDT) using polymeric photosensitizers is a promising therapeutic strategy for cancer treatment. In this study, we synthesized a pHPMA conjugated pyropheophorbide-a (P-PyF) as a cancer theranostic agent for PDT and photodynamic diagnostics (PDD). Pyropheophorbide-a has one carboxyl group which was conjugated to pHPMA via amide bond yielding the intended product with high purity. In aqueous solutions, P-PyF showed a mean particle size of approximately 200 nm as it forms micelle which exhibited fluorescence quenching and thus very little singlet oxygen (1O2) production. In contrast, upon disruption of micelle strong fluorescence and 1O2 production were observed. In vitro study clearly showed the PDT effect of P-PyF. More potent 1O2 production and PDT effect were observed during irradiation at approximately 420 nm, the maximal absorbance of pyropheophorbide-a, than irradiation at longer wavelength (i.e., approximately 680 nm), suggesting selection of proper absorption light is essential for successful PDT. In vivo study showed high tumor accumulation of P-PyF compared with most of normal tissues due to the enhanced permeability and retention (EPR) effect, which resulting in superior antitumor effect under irradiation using normal xenon light source of endoscope, and clear tumor imaging profiles even in the metastatic lung cancer at 28 days after administration of P-PyF. On the contrary irradiation using long wavelength (i.e., approximately 680 nm), the lowest Q-Band, exhibited remarkable tumor imaging effect with little autofluorescence of background. These findings strongly suggested P-PyF may be a potential candidate-drug for PDT/PDD, particularly using two different wavelength for treatment and detection/imaging, respectively.
    WorkplaceInstitute of Macromolecular Chemistry
    ContactEva Čechová, cechova@imc.cas.cz ; Tel.: 296 809 358
    Year of Publishing2019
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.